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Introduction
Previous ultrasound studies demonstrated the adverse
effect of the metabolic syndrome (MS) on aortic stiffness
and left ventricular (LV) diastolic function. However, the
exact underlying mechanism responsible for these
changes is largely unknown and has not yet been studied
with magnetic resonance imaging (MRI).
Purpose
To evaluate the influence of metabolic deregulation on
aortic function and LV diastolic function in subjects with
the MS using MRI.
Methods
MRI was performed in 16 male subjects with the MS and
16 male subjects without the MS who were matched for
age, waist circumference and blood pressure. MS was
defined using the IDF criteria. Pulse wave velocity (PWV)
in the aortic arch and the descending aorta were used as
markers for aortic stiffness. Transmitral flow measure-
ments were acquired for evaluation of LV diastolic func-
tion. Mean and peak deceleration of the early filling wave
(E) were derived. The independent students T-test was
used to evaluate differences between the two groups. The
association between the separate components of the MS
and MRI variables reflecting aortic stiffness and LV diasto-
lic function were calculated using Pearson's correlation
coefficient.
Results
Due to matching, age, waist circumference and blood
pressure values were similar between the two groups (age:
60 ± 5 and 59 ± 4 years, p = 0.9, waist circumference: 111
± 11 vs. 106 ± 9 cm, p = 0.2, systolic blood pressure: 145
± 17 vs. 142 ± 17 mmHg, p = 0.6, diastolic blood pressure:
88 ± 8 vs. 89 ± 9 mmHg, p = 0.9 resp. in subjects with and
without the MS). PWV in the aortic arch and descending
aorta was higher in subjects with the MS (7.6 ± 2.2 vs. 5.7
± 1.1 m/s, p < 0.01 and 7.3 ± 1.9 vs. 6.1 ± 1.1 m/s, p <
0.05). LV diastolic function was diminished in subjects
with MS compared to subjects without MS (peak E decel-
eration:-3.7 ± 1.0 vs. -4.6 ± 1.3 ml/s2, p < 0.05 and mean
E deceleration:-2.4 ± 0.7 vs. -3.0 ± 0.9 ml/s2, p < 0.05).
PWV in the aortic arch and total aorta (aortic arch and
descending aorta) correlated with HDL-cholesterol (resp.
r = -0.514, p = 0.003 and r = -0.470, p = 0.007). Further-
more, HDL cholesterol correlated with mean deceleration
of the E wave (resp. r = -0.421, p = 0.021). No significant
correlation was observed between the other components
of the MS and aortic or cardiac function.
Conclusion
Metabolic deregulation in patients with the MS, in partic-
ular low HDL-cholesterol, is related with adverse cardio-
vascular changes, regardless of blood pressure.
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